Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Jerel Zoltick who wrote (2678)	8/27/1998 12:11:00 AM
From: Toni Wheeler	Read Replies (1) \| Respond to of 3725

Well put, Jerel. Courtesy of another thread, this article is VERY interesting and appropriate for the prior discussion on valuation: rcmfinancial.com. Being the non-financial type, I think I need some interpretation!! How can we apply this information/rationalization to IMAT?? Comments, please! ~T.

To: Jerel Zoltick who wrote (2678)	9/1/1998 11:29:00 PM
From: art slott	Read Replies (1) \| Respond to of 3725

Closer to the Holy Grail Because the CT scan can accurately gauge the extent of heart disease, it should be helpful in determining whether patients have disease that is advanced enough to warrant taking medications, Guerci said. "This should be helpful for people whose doctors say, 'Your cholesterol is a little high,' or 'Your blood pressure is a little high,''' he explained. "The really attractive feature of this test is its potential as a screening test for the early detection of coronary disease in people who have no symptoms,''